Cleerly
Precision heart care platform analyzing coronary CT angiography to evaluate plaque buildup.
What they do
The company provides artificial intelligence software that analyzes non-invasive coronary CT angiograms to measure and characterize plaque in heart arteries. It helps cardiologists identify heart disease before patients exhibit warning signs.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Cardiovascular diagnostics
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Denver, USA
- Region
- North America
- Founded
- 2017
- Total funding
- $248M raised
Notable investors: T. Rowe Price, Fidelity, Sands Capital, LRVHealth.